Adaptive Biotechnologies Insider Sold: What Investors Should Know
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
Glide path describes how a target date fund changes its asset mix as the target year approaches, balancing risk and growth for your retirement.
25,488 articlesInsider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
Real Brokerage and REMAX will vote virtually on August 14 to approve a merger that would create the Real REMAX Group....
June's jet deliveries offer a clear signal about Boeing's momentum as it nears the July earnings report. This article...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
Three meme-rooted retail names are in focus as markets wobble: Kohl's, Chewy, and Wayfair are drawing fresh bets from...
Lucid Group bucked volatility in the electric-vehicle space, rising for a third consecutive session and surpassing ke...
Point launches a third-party origination channel for its HEI product and names Samuel Bjelac as wholesale chief, aimi...
LuxExperience reports solid Q3 2026 results with growing revenue and improving margins. This article breaks down the ...
USO has surged nearly 100% this year as Hormuz shutdowns persisted. A reopening could spark a swift unwind.
Investors are buzzing after Simulations Plus announced a cash buyout at $18.50 per share. This deep-dive explains why...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
A July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...